Phase 2 N=11 Chewed vs. Crushed Lanthanum Carbonate in Hemodialysis Patients
Hyperphosphatemia · Kidney Disease
Primary: Serum Phosphorous Concentration — 2.0; 1.7 mg/dL
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=178 Relational Agent for Alcohol Screening and Treatment
Unhealthy Alcohol Use · Alcohol Use Disorder · Alcohol Disorders
Primary: Drinks Per Drinking Day (DDPW) — 2.98; 4.00; 1.87; 2.82 drinks per drinking day
Phase 4 N=40 Effect of Dexmedetomidine on Postoperative Glucose and Insulin Levels.
Bariatric Surgery Candidate · Glucose Intolerance · Insulin Resistance
Primary: Plasmatic Glucose Levels (mg/dl). — 80; 82; 114; 111 mg/dl — p=0.38
N/A N=50 A Clinical Evaluation of the Sinexus Intranasal Splint Following Functional Endoscopic Sinus Surgery in Patients With Chronic Rhinosinusitis
Chronic Sinusitis
Primary: Device Success Rate — 14; 76; 10 ethmoid sinuses
Phase 2 N=40 Efficacy and Safety of Lanreotide Autogel (ATG) in Combination With Temozolomide in Subjects With Thoracic Neuroendocrine Tumors.
Neuroendocrine Tumours
Primary: Disease Control Rate (DCR) Assessed Locally at Month 9 — 35.0; 45.2; 45.0 percentage of participants — p=0.2968
Phase 4 N=64 Randomized Trial of Wound Infiltration With Extended-release Bupivacaine Before Laparoscopic or Robotic Hysterectomy
Pain, Postoperative · Surgical Procedure, Unspecified
Primary: Numerical Rating Scale (NRS) Post-operative Pain Score on Post-Operative Day 1 (POD1). — 4.17; 4.97 units on a scale
N/A N=57 Evaluation of Cogmed Working Memory Training for Adult Hearing Aid Users
Hearing Loss
Primary: Visual Letter Monitoring Task — 8.48; 8.27; 8.07; 8.73 score on a scale
Phase 2 N=11 Pilot Study of Melatonin and Epilepsy
Epilepsy
Primary: Sleep Latency Wakefulness After Sleep Onset (WASO) — 42.3; 57.3 minutes/night
N/A N=687 Vitamins in Nitrous Oxide Study
Major Surgery · Coronary Artery Disease
Primary: Myocardial Ischemia — 33; 34; 17; 217 Participants
N/A N=130 Trial of Self-managed Approaches for Patellofemoral Pain Syndrome in Active Duty
Patellofemoral Pain Syndrome
Primary: Lower Extremity Muscle Strength- Extension — 41.58; 37.74; 37.14; 40.42 Kg-Force
Phase 2 N=47 Assessing the Safety of Buprenorphine in People With Sickle Cell Disease
Sickle Cell Disease
Primary: Number of Subjects Who Require Hospitalization Within 72 Hours Post Conversion From Full Agonist Opioids to Buprenorphine-based Pain Treatment — 1 Participants
N/A N=11 Long-term Effect of Low Frequency Stimulation on Aspiration and Freezing of Gait in PD With STN DBS
Parkinson's Disease
Primary: Frequency of Aspiration Events on Videofluoroscopic Swallow Study at Visit 1 — 0.6; 2.9; 1.2 score on a scale — p=<0.05
N/A N=30 Evaluation of Capsule Endoscopy With PillCam® Colon 2 in Visualization of the Colon
Colorectal Lesions
Primary: Accuracy of the PillCam® Colon 2 Capsule Endoscopy (CE) for Polyps Per Subject - Sensitivity — 83; 50 percentage of sensitivity
Phase 2 N=108 A Study of Bryostatin in Moderately Severe to Severe Alzheimer's Disease Subjects Not On Memantine
Alzheimer Disease
Primary: Safety: Treatment Emergent Adverse Events (AEs) and Serious Adverse Events (SAEs) — 21; 10 Participants
N/A N=82 China Micra Transcatheter Pacing Study
Bradycardia
Primary: Percentage of Participants With Major Complications Free Survival Probability — 97.6 percentage of participants — p=0.0021